Compare CSGP & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSGP | IDXX |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.6B | 51.1B |
| IPO Year | 1998 | 1991 |
| Metric | CSGP | IDXX |
|---|---|---|
| Price | $68.16 | $700.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | $94.08 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 3.5M | 592.4K |
| Earning Date | 10-28-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.65 |
| EPS | 0.05 | ★ 12.60 |
| Revenue | $3,056,500,000.00 | ★ $4,167,411,000.00 |
| Revenue This Year | $20.71 | $12.15 |
| Revenue Next Year | $18.04 | $8.79 |
| P/E Ratio | $1,391.47 | ★ $55.56 |
| Revenue Growth | ★ 14.61 | 8.39 |
| 52 Week Low | $63.82 | $356.14 |
| 52 Week High | $97.43 | $769.98 |
| Indicator | CSGP | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 49.31 |
| Support Level | $67.16 | $693.72 |
| Resistance Level | $68.58 | $716.45 |
| Average True Range (ATR) | 1.39 | 17.46 |
| MACD | 0.38 | -5.83 |
| Stochastic Oscillator | 69.36 | 13.64 |
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.